DK1828137T3 - 4-Cycloalkyl-substituerede tetrahydroquinolinderivater og deres anvendelse som medikamenter - Google Patents
4-Cycloalkyl-substituerede tetrahydroquinolinderivater og deres anvendelse som medikamenterInfo
- Publication number
- DK1828137T3 DK1828137T3 DK05820528.7T DK05820528T DK1828137T3 DK 1828137 T3 DK1828137 T3 DK 1828137T3 DK 05820528 T DK05820528 T DK 05820528T DK 1828137 T3 DK1828137 T3 DK 1828137T3
- Authority
- DK
- Denmark
- Prior art keywords
- cycloalkyl
- drugs
- tetrahydroquinoline derivatives
- substituted tetrahydroquinoline
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Quinoline Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004060997A DE102004060997A1 (de) | 2004-12-18 | 2004-12-18 | Chemische Verbindung und ihre Verwendung |
DE102004061000A DE102004061000A1 (de) | 2004-12-18 | 2004-12-18 | Chemische Verbindung und ihre Verwendung |
PCT/EP2005/013490 WO2006063828A1 (de) | 2004-12-18 | 2005-12-15 | 4-cycloalkyl-substituierte tetrahydrochinolinderivate und deren verwendung als medikamente |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1828137T3 true DK1828137T3 (da) | 2012-07-23 |
Family
ID=35841894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05820528.7T DK1828137T3 (da) | 2004-12-18 | 2005-12-15 | 4-Cycloalkyl-substituerede tetrahydroquinolinderivater og deres anvendelse som medikamenter |
Country Status (27)
Country | Link |
---|---|
US (2) | US8124775B2 (da) |
EP (1) | EP1828137B1 (da) |
JP (1) | JP5132317B2 (da) |
KR (1) | KR20070090248A (da) |
AR (1) | AR055011A1 (da) |
AT (1) | ATE555097T1 (da) |
AU (1) | AU2005315770B2 (da) |
BR (1) | BRPI0519602A2 (da) |
CA (1) | CA2591397A1 (da) |
CU (1) | CU23452B7 (da) |
CY (1) | CY1112887T1 (da) |
DK (1) | DK1828137T3 (da) |
DO (1) | DOP2005000259A (da) |
ES (1) | ES2384980T3 (da) |
GT (1) | GT200500377A (da) |
IL (1) | IL184008A (da) |
MA (1) | MA29100B1 (da) |
MX (1) | MX2007007188A (da) |
NO (1) | NO20073146L (da) |
PE (1) | PE20060767A1 (da) |
PL (1) | PL1828137T3 (da) |
PT (1) | PT1828137E (da) |
RU (1) | RU2393151C2 (da) |
SI (1) | SI1828137T1 (da) |
TW (1) | TW200635900A (da) |
UY (1) | UY29276A1 (da) |
WO (1) | WO2006063828A1 (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0519566A2 (pt) * | 2004-12-18 | 2009-01-27 | Bayer Healthcare Ag | derivados de (5s)-3-[(s)-fléor(4-trifluormetilfenil)metil]-5,6,7,8-tet raidroquinolin-5-ol e seu uso como inibidores de cetp |
DE102006012548A1 (de) * | 2006-03-18 | 2007-09-20 | Bayer Healthcare Ag | Substituierte Chromanol-Derivate und ihre Verwendung |
ES2372012T3 (es) * | 2008-03-05 | 2012-01-12 | Boehringer Ingelheim International Gmbh | Derivados de piridina tricíclicos, medicamentos que contienen a estos compuestos, su uso y procedimiento para su preparación. |
SG183321A1 (en) | 2010-02-19 | 2012-09-27 | Boehringer Ingelheim Int | Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
MX2013000359A (es) * | 2010-07-09 | 2013-02-11 | Ube Industries | Compuesto de piridina sustituida. |
US20130053404A1 (en) | 2011-02-17 | 2013-02-28 | Boehringer Ingelheim International Gmbh | Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
AR087577A1 (es) | 2011-08-17 | 2014-04-03 | Boehringer Ingelheim Int | Derivados de furo[3,4-c]quinolina, medicamentos que contienen dichos compuestos, su uso y proceso para su preparacion |
CA2860601C (en) | 2012-01-06 | 2016-07-05 | Daiichi Sankyo Company, Limited | Acid addition salt of substituted pyridine compound |
KR102456013B1 (ko) | 2014-07-30 | 2022-10-18 | 에프. 호프만-라 로슈 아게 | 고밀도 지질단백질(hdl)-상승 제제 또는 hdl-모방 제제에 의한 치료법에 대한 반응성을 예측하기 위한 유전 표지 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19610932A1 (de) * | 1996-03-20 | 1997-09-25 | Bayer Ag | 2-Aryl-substituierte Pyridine |
US6207671B1 (en) * | 1996-07-08 | 2001-03-27 | Bayer Aktiengesellschaft | Cycloalkano-pyridines |
HRP970330B1 (en) * | 1996-07-08 | 2004-06-30 | Bayer Ag | Cycloalkano pyridines |
DE19627431A1 (de) * | 1996-07-08 | 1998-01-15 | Bayer Ag | Heterocyclisch kondensierte Pyridine |
DE19627430A1 (de) * | 1996-07-08 | 1998-01-15 | Bayer Ag | Bicyclisch kondensierte Pyridine |
DE19704244A1 (de) * | 1997-02-05 | 1998-08-06 | Bayer Ag | 5-Hydroxy-alkyl substituierte Phenyle |
DE19709125A1 (de) | 1997-03-06 | 1998-09-10 | Bayer Ag | Substituierte Chinoline |
DE19741051A1 (de) * | 1997-09-18 | 1999-03-25 | Bayer Ag | Hetero-Tetrahydrochinoline |
MA24643A1 (fr) * | 1997-09-18 | 1999-04-01 | Bayer Ag | Tetrahydro-naphtalenes substitues et composes analogues |
DE19741399A1 (de) * | 1997-09-19 | 1999-03-25 | Bayer Ag | Tetrahydrochinoline |
DE19935966A1 (de) | 1999-07-30 | 2001-02-01 | Bayer Ag | Verfahren zur Reduktion von Ketoalkoholen |
DE10148436A1 (de) * | 2001-10-01 | 2003-04-17 | Bayer Ag | Tetrahydrochinoline |
DE10250687A1 (de) * | 2002-10-31 | 2004-05-13 | Bayer Ag | 7H-Dibenzo(b,g)(1,5)dioxocin-5-on-Derivate und ihre Verwendung |
BRPI0519566A2 (pt) * | 2004-12-18 | 2009-01-27 | Bayer Healthcare Ag | derivados de (5s)-3-[(s)-fléor(4-trifluormetilfenil)metil]-5,6,7,8-tet raidroquinolin-5-ol e seu uso como inibidores de cetp |
-
2005
- 2005-12-15 BR BRPI0519602-7A patent/BRPI0519602A2/pt not_active IP Right Cessation
- 2005-12-15 AT AT05820528T patent/ATE555097T1/de active
- 2005-12-15 CA CA002591397A patent/CA2591397A1/en not_active Abandoned
- 2005-12-15 US US11/793,482 patent/US8124775B2/en not_active Expired - Fee Related
- 2005-12-15 AU AU2005315770A patent/AU2005315770B2/en not_active Ceased
- 2005-12-15 PL PL05820528T patent/PL1828137T3/pl unknown
- 2005-12-15 PT PT05820528T patent/PT1828137E/pt unknown
- 2005-12-15 EP EP05820528A patent/EP1828137B1/de not_active Not-in-force
- 2005-12-15 MX MX2007007188A patent/MX2007007188A/es active IP Right Grant
- 2005-12-15 ES ES05820528T patent/ES2384980T3/es active Active
- 2005-12-15 RU RU2007127127/04A patent/RU2393151C2/ru not_active IP Right Cessation
- 2005-12-15 KR KR1020077016219A patent/KR20070090248A/ko not_active Application Discontinuation
- 2005-12-15 DK DK05820528.7T patent/DK1828137T3/da active
- 2005-12-15 WO PCT/EP2005/013490 patent/WO2006063828A1/de active Application Filing
- 2005-12-15 JP JP2007545948A patent/JP5132317B2/ja not_active Expired - Fee Related
- 2005-12-15 SI SI200531547T patent/SI1828137T1/sl unknown
- 2005-12-16 TW TW094144588A patent/TW200635900A/zh unknown
- 2005-12-16 DO DO2005P000259A patent/DOP2005000259A/es unknown
- 2005-12-16 AR ARP050105313A patent/AR055011A1/es not_active Application Discontinuation
- 2005-12-16 PE PE2005001475A patent/PE20060767A1/es not_active Application Discontinuation
- 2005-12-19 GT GT200500377A patent/GT200500377A/es unknown
- 2005-12-20 UY UY29276A patent/UY29276A1/es not_active Application Discontinuation
-
2007
- 2007-06-18 MA MA30003A patent/MA29100B1/fr unknown
- 2007-06-18 CU CU20070140A patent/CU23452B7/es not_active IP Right Cessation
- 2007-06-18 IL IL184008A patent/IL184008A/en not_active IP Right Cessation
- 2007-06-19 NO NO20073146A patent/NO20073146L/no not_active Application Discontinuation
-
2012
- 2012-02-16 US US13/398,290 patent/US20120142728A1/en not_active Abandoned
- 2012-06-29 CY CY20121100588T patent/CY1112887T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
RU2393151C2 (ru) | 2010-06-27 |
UY29276A1 (es) | 2006-07-31 |
IL184008A0 (en) | 2007-10-31 |
WO2006063828A1 (de) | 2006-06-22 |
AR055011A1 (es) | 2007-08-01 |
RU2007127127A (ru) | 2009-01-27 |
BRPI0519602A2 (pt) | 2009-02-25 |
GT200500377A (es) | 2006-11-09 |
ATE555097T1 (de) | 2012-05-15 |
SI1828137T1 (sl) | 2012-08-31 |
EP1828137A1 (de) | 2007-09-05 |
US20080255068A1 (en) | 2008-10-16 |
KR20070090248A (ko) | 2007-09-05 |
NO20073146L (no) | 2007-09-18 |
US8124775B2 (en) | 2012-02-28 |
EP1828137B1 (de) | 2012-04-25 |
CU23452B7 (es) | 2009-12-01 |
PL1828137T3 (pl) | 2012-09-28 |
US20120142728A1 (en) | 2012-06-07 |
MA29100B1 (fr) | 2007-12-03 |
DOP2005000259A (es) | 2006-11-15 |
PE20060767A1 (es) | 2006-09-10 |
CA2591397A1 (en) | 2006-06-22 |
CY1112887T1 (el) | 2016-04-13 |
MX2007007188A (es) | 2007-08-14 |
AU2005315770A1 (en) | 2006-06-22 |
ES2384980T3 (es) | 2012-07-16 |
PT1828137E (pt) | 2012-07-04 |
TW200635900A (en) | 2006-10-16 |
IL184008A (en) | 2012-03-29 |
JP2008524145A (ja) | 2008-07-10 |
AU2005315770B2 (en) | 2011-12-08 |
JP5132317B2 (ja) | 2013-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1928457T3 (da) | Quinoliner og deres terapeutiske anvendelse | |
DK1761529T3 (da) | Pyrrolopyridinderivater og deres anvendelse som CRTh2-antagonister | |
DK1578755T3 (da) | Phosphonooxyguinalinderivater og deres farmaceutiske anvendelse | |
DK2049525T3 (da) | N-laminoheteroaryl)-1H-indol-2-carboxamid-derivater, og fremstilling og terapeutisk anvendelse deraf | |
ATE415400T1 (de) | Pyrazolopyridinderivate | |
IS8578A (is) | 3- karbamoýl - 2- pýridón afleiður | |
DK1954140T3 (da) | Glycerollevulinatketaler og deres anvendelse | |
DK1725553T3 (da) | Tetrahydropyridoindolderivater | |
MA29039B1 (fr) | Dibenzylamines et derives | |
DK1761541T3 (da) | Pyrrazolo-pyrimidin-derivater | |
ATE540935T1 (de) | Chinazolinderivate | |
DK1732892T3 (da) | Tetrahydrocarbazoler og derivater | |
NL1031473A1 (nl) | Cyclopentapyridine- en tetrahydrochinolinederivaten. | |
ATE417830T1 (de) | Sulfonylbenzimidazolderivate | |
DK1922309T3 (da) | N-phenyl-2-pyrimidin-aminderivater og fremgangsmåde til fremstillingen deraf | |
DK1723135T3 (da) | Kendte hydroxy-6-heteroarylphenanthridiner og deres anvendelse som pde4-inhibitorer | |
DK1773796T3 (da) | Oxopiperidinderivater, fremstilling deraf samt terapeutisk anvendelse deraf | |
DK1828137T3 (da) | 4-Cycloalkyl-substituerede tetrahydroquinolinderivater og deres anvendelse som medikamenter | |
DK1709018T3 (da) | Acylaminothiazolderivater og anvendelse deraf som beta-amyloid-hæmmere | |
DK1885716T3 (da) | Thiazolderivater og anvendelse deraf | |
DK1753725T3 (da) | Tetra-hydro-iso-quinolinsulfonamidderivater, fremstilling og terapeutisk anvendelse heraf. | |
ATE420081T1 (de) | Trifluormethylbenzamidderivate und therapeutische verwendungen dafür | |
ATE430142T1 (de) | Phenylpiperazin-methanon-derivate | |
DK1912644T3 (da) | N-(arylalkyl)-1h-pyrrolopyridin-2-carboxamid-derivater, fremstilling deraf og terapeutisk anvendelse deraf | |
DK1773829T3 (da) | Aminotropanderivater, fremstilling og terapeutiske anvendelser heraf |